Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular
Free webinar: Telepathology: is there added value in LMICs?
Free webinar: Telepathology: is there added value in LMICs?

Centrosomes in ovarian cancer

Dr Fanni Gergely - CRUK Cambridge Institute
Centrosomes in ovarian cancer ( Dr Fanni Gergely - CRUK Cambridge Institute )
27 Apr 2017

Diagnosing cancerous and precancerous oesophageal disease

Prof Rebecca Fitzgerald - University of Cambridge, Cambridge, UK
Diagnosing cancerous and precancerous oesophageal disease ( Prof Rebecca Fitzgerald - University of Cambridge, Cambridge, UK )
27 Apr 2017

Hallmarks of cancer cell development

Dr Douglas Hanahan - Swiss Institute for Experimental Cancer Research, Lausanne, Switzerland
Hallmarks of cancer cell development ( Dr Douglas Hanahan - Swiss Institute for Experimental Cancer Research, Lausanne, Switzerland )
27 Apr 2017

Genome stability in potentially immortal planarian stem cells

Sounak Sahu - University of Oxford, Oxford, UK
Genome stability in potentially immortal planarian stem cells ( Sounak Sahu - University of Oxford, Oxford, UK )
27 Apr 2017

Global horizons of the WIN consortium

Dr Vladimir Lazar - Chief Operating Officer, WIN Consortium
Global horizons of the WIN consortium ( Dr Vladimir Lazar - Chief Operating Officer, WIN Consortium )
27 Apr 2017

What is the WIN Consortium?

Dr John Mendelsohn - Chairman of the WIN Consortium
What is the WIN Consortium? ( Dr John Mendelsohn - Chairman of the WIN Consortium )
27 Apr 2017

Pembrolizumab and indoximod for melanoma

Prof Yousef Nabih Zakharia - Holden Comprehensive Cancer Center, University of Iowa, Iowa City, USA
Pembrolizumab and indoximod for melanoma ( Prof Yousef Nabih Zakharia - Holden Comprehensive Cancer Center, University of Iowa, Iowa City, USA )
13 Apr 2017

Projections of cancer incidence and burden among the HIV-positive population in the United States through 2030

Jessica Yasmine Islam - University of North Carolina, Chapel Hill, USA
Projections of cancer incidence and burden among the HIV-positive population in the United States through 2030 ( Jessica Yasmine Islam - University of North Carolina, Chapel Hill, USA )
12 Apr 2017

Nivolumab for NSCLC: five years on

Prof Julie Brahmer - Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA
Nivolumab for NSCLC: five years on ( Prof Julie Brahmer - Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA )
12 Apr 2017

Avelumab for metastatic Merkel cell carcinoma after chemotherapy

Dr Howard Kaufman - Rutgers Cancer Institute of New Jersey, New Brunswick, USA
Avelumab for metastatic Merkel cell carcinoma after chemotherapy ( Dr Howard Kaufman - Rutgers Cancer Institute of New Jersey, New Brunswick, USA )
12 Apr 2017

Nivolumab and ipilimumab combination for advanced skin cancer

Dr James Larkin - The Royal Marsden, London, UK
Nivolumab and ipilimumab combination for advanced skin cancer ( Dr James Larkin - The Royal Marsden, London, UK )
12 Apr 2017

Long-term clinical outcomes and analyses of atezolizumab for mTNBC

Prof Peter Schmid - Barts Cancer Institute, London, UK
Long-term clinical outcomes and analyses of atezolizumab for mTNBC ( Prof Peter Schmid - Barts Cancer Institute, London, UK )
12 Apr 2017

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation